Post on 05-Jun-2020
transcript
Reducing 30-day Rehospitalization for Heart Failure: An Attainable Goal?
Reducing 30-day Rehospitalization for Heart Failure: An Attainable Goal?
Ileana L. Piña, MD, MPHProfessor of Medicine, Epi/BiostatsCase Western Reserve University
Graduate VA Quality ScholarCleveland Ohio
If we want to work with a system to influence its direction -- a normal
desire as we work with human organizations--the place for us to
work is deep in the dynamics of the system where [its] identity is taking
form.
Wheatley & Kellnor-Rogers, 1996
Contemporary Application of Evidence-based Care for Acute and Chronic Heart Failure Contemporary Application of Evidence-based Care for Acute and Chronic Heart Failure
• Heart failure results in substantial morbidity and mortality
• Fortunately, a number of evidence-based, life-prolonging drug and device therapies have been developed and are now widely available for managing patients with heart failure
• Despite overwhelming clinical-trial evidence, expert opinion, national guidelines, and a vast array of educational conferences, these evidence-based, life-prolonging drug and device therapies continue to be underutilized in both the inpatient and outpatient settings
Fonarow GC. Rev Cardiovasc Med. 2002;3:S2-S10.
Definition of Quality
“Degree to which health care services increase the likelihood of desired health outcomes and are consistent with current professional knowledge”
– Are you doing the right things?
– Are your patients better off for it?
Challenges in Measuring HF Quality of Care
• HF is not a single entity– Systolic vs diastolic HF– Etiology (ischemic vs other)– Severity (NYHA class I-IV)
• Limited data on what processes works, particularly in the acute setting
• Even less information how process of care delivery factors affect outcomes
• Longitudinal disease– Yet measurement often cross-sectional
Heart failure readmission
rates are quite high.
Almost half of the patients were readmitted within6 months
Copyright CWRU-CME 2003All Rights Reserved
Heart Failure is the most common reason for 30 day reshospitalization
nn Jencks et al.Jencks et al. N Engl J Med 2009;360:1418-28.
Copyright CWRU-CME 2003All Rights Reserved
Copyright CWRU-CME 2003All Rights Reserved
Krumholz, H. M. et al. Circ Cardiovasc Qual Outcomes 2009;2:407-413
Heart failure 30Heart failure 30--day Riskday Risk--Standardized Standardized Readmission Rate DistributionReadmission Rate Distribution
ADHERE Variation in ACE Inhibitor Use for HF ADHERE Variation in ACE Inhibitor Use for HF
ADHERE: Dec 2002, 206 Hospitals; 23,193 patients (subset with LVEF ≤
.40, no CI)
Fonarow GC et al. Arch Intern Med. 2005;165:1469-1477.
ORYX Core Measure: HF 3 - LVEF < 40% prescribed ACEI at discharge
Rate
(%)
020
4060
8010
0
ADHERE Hospitals
Outcomes in Patients Hospitalized With HFOutcomes in Patients Hospitalized With HF
Fonarow, GC. Rev Cardiovasc Med. 2002;3(suppl 4):S3Jong P et al. Arch Intern Med. 2002;162:1689
0
25
50
75
100
20%
50%
30Days
6Months
Hospital Readmissions
0
25
50
75
100
12%
50%
30Days
12Months
Mortality
33%
5Years
Mean LOS: 6.5 days Annual mortality rate-NYHA class III HF-12% [COPERNICUS DATA]NYHA class II HF-7% [SCD-HeFT DATA]
HF readmission can be decreased.
Comprehensive discharge planning plus post- discharge support for older patients with CHF significantly reduced readmission rates and may improve health outcomes such as survival and QOL without increasing costs.
Copyright CWRU-CME 2003All Rights Reserved
52% of heart failure patients are not seen in the first 30 days after a hospitalization
nn Jencks et al. Jencks et al. N Engl J Med 2009;360:1418-28
Why Does it Matter to Providers?Why Does it Matter to Providers?
• Putting the patient first• Improving transitions of care• The right treatment at the right time for the right reason for
all patients• Fulfilling requirements • Finding opportunities to improve care• Use measurement as a tool to create an imperative to
improve and provide perspective regarding performance• Clinicians should engage constructively in this effort and
should examine adverse outcomes within their institutions
Relative-Risk 2 Year Mortality
None - - 35%
ACE Inhibitor 23% 27%
Aldosterone Ant 30% 19%
Beta-Blocker 35% 12%
CRT +/- ICD 36% 8%
Cumulative risk reduction if all four therapies are used: 77%Absolute risk reduction: 27%, NNT = 4
Updated from Fonarow GC. Rev Cardiovasc Med. 2000;1:25-33.
Cumulative Impact of Heart Failure Therapies
Cumulative Impact of Heart Failure Therapies
Is it omission, or commission in the hospital stay?????
Inadequate diuresis without other considerations? Removal of life-saving therapies? Fear of hypotension, renal dysfunction? Avoiding phone calls? No uptitration Late visits
Is it omission, or commission in the hospital stay?????
Inadequate diuresis without other considerations? Removal of life-saving therapies? Fear of hypotension, renal dysfunction? Avoiding phone calls? No uptitration Late visits
Source: Wall Street Journal
8% 7%
13%
24%
32%
11%
3% 2%
0
5
10
15
20
25
30
35
(<-20) (–20 to –15)(-15 to –10)(–10 to –5)(–5 to 0) (0 to 5) (5 to 10) (>10)
Change in Weight (lbs)
No Mention
11%
Asymptomatic44%
Improved
(but still
symptomatic)40%
Clinical Status at Discharge Evidence for Incomplete Relief from Congestion
Fonarow GC. Rev Cardiovasc Med. 2003; 4 (Suppl. 7): 21
Medication Change Analysis Medication Change Analysis
p=0.0044p=0.0044
p=0.0025p=0.0025
p<0.001p<0.001
5.13
4.02
2.11
0.20 0.18 0.23
4.02
2.97
1.37
0.15 0.23 0.19
0
1
2
3
4
5
6
All Drugs All CV Drugs Diuretics ACE/ARB Beta Blockers Vasodilators/Nitrates
Cha
nges
/ Pa
tient
Mon
th
CHRONICLE CONTROL
2 6
Large Treatment Gaps for Newer Guideline Recommended Therapies Including ICD
25
0.6
2624
1.6
2824
3.5
2624
3.2
2624
8.6
25
0102030405060708090
100
Aldosterone Antagonist Hyd/Nitrates in Black Pts ICD in LVEF <= 30%
Baseline Q1 Q2 Q3 Q4
P=0.0017
Data from 97 GWTG-HF hospitals and 18,516 HF patients were collected from 1/05-3/06Fonarow GC et al. AHA 2006 abstract
P<0.0001
P=0.0498
Years 2005 to 2006
Yancy CW et al. HFSA 2008 abstract
Variation in HF Quality of Care in US Cardiology Practices: IMPROVE-HF
The frequency distribution of conformity rates by practice
Use of Hydralazine/Nitrates in Black Patients
Median, 0.0Mean, 7.3
2 8
Mean Dose and Frequency of Dose Changes of β-Blockade Post HF Hospital Discharge
Mean Daily Dose (mg)
At Discharge At 60-90 day Follow-up
Carvedilol 17.8 ± 17.5 20.3 ± 17.3
Newly started on carvedilol 12.5 ± 14.2 16.9 ± 15.2
Metoprolol succinate 68.3 ± 52.8 68.7 ± 52.2
Newly started on metoprolol succinate 57.5 ± 47.9 68.6 ± 57.8
Immediate-release metoprolol tartrate 81.7 ± 55.2 82.2 ± 56.4
Atenolol 43.7 ± 30.9 47.1 ± 37.8
Fonarow GC, et al. Am J Cardiol 2008;102:1524-9
Continuity of HF Care Reliable Care: Not Missing the Steps Continuity of HF Care Reliable Care: Not Missing the Steps
Fonarow GC. Rev Cardiovasc Med. 2006;7:S3-11.
OutpatientOutpatient
•• On right meds?On right meds?•• On right dose?On right dose?•• Volume statusVolume status•• ReRe--assess EFassess EF•• Device?Device?•• Self Manage?Self Manage?•• Other Issues? Other Issues?
Early Early Post DCPost DC
•• Right meds?Right meds?•• TitrationTitration•• Pt Pt
EducationEducationDiseaseDiseaseManageManage
•• ContinuityContinuityDevice?Device?
DCDC
•• Oral MedsOral Meds•• Other Rx?Other Rx?•• Other evalOther eval•• Pt EdPt Ed•• F/UF/U•• DiseaseDisease
ManageManage
CCUCCUTelemetryTelemetry
•• IV MedsIV Meds•• Oral MedsOral Meds•• LV functionLV function•• Echo and/orEcho and/or
Cath?Cath?•• OtherOther
EvaluationEvaluation•• Tx to FloorTx to Floor
HospitalHospitalEDED
• • DiagnosisDiagnosis•• Admit Admit
•• CCU?CCU?•• Acute RxAcute Rx
•• EvaluationEvaluation
* Who is responsible????
Black hole* Black hole*
Black hole* Black hole*
The “Perilous”
Time• 40% of HF patients do not get discharged to
home– Skilled Nursing Facility– Long Term Care– Rehabilitation Facility
• Home discharge– Hospital Home– Visiting Nurse– Home physician visits
• Timing to next decompesation
Causes of Hospital Readmission for Congestive Heart Failure
17%Other
19%Failure to Seek
Care
16%Inappropriate Rx
Rx Noncompliance24%
Diet Noncompliance24%
Annals of Internal Medicine 122:415-21, 1995
Over 2/3 of HF Hospitalizations Preventable
Post d/c monitoring
Patient or Clinician driven
Home visits
• Home based nursing with special training in HF
Stewart S, et al. Circulation 2002;105:2861
Efficacy of Heart Failure Management Programs
Copyright CWRU-CME 2003All Rights Reserved
6-Month All Cause Mortality Rates by Randomization Arm
0%
10%
20%
30%
40%
50%
60%
0 50 100 150 200
Alere Standard Care
Days After Study Entry
p=0.24
11.2%
7.0%
All-
caus
e m
orta
lity
How we improvewhat we make
What society needs
How we create, make health care
Understanding health care Understanding health care as a systemas a system
Tools are critical
♦ “Aid” to practitioners to apply “best care”♦Making tools attractive by not “adding more
work”♦Non threatening♦Easily integrated into the current practice♦Need to understand better the barriers that
exist to implement quality measures♦Promoted by physician “champions”
The Heart Failure Continuum• A successful care process must
address ALL areas of heart failure care– SNF care– Ambulatory clinic care– ED decisions to send– Home health care when discharged home
• Goals:– Decrease hospitalizations– Decrease length of stay– Improve QOL– Prolong survival– Improve symptoms
Copyright CWRU-CME 2003All Rights Reserved
Integration Of The Care Process
HF teamHF patient
Hospital, clinic,referring MD
Flow ofinformation
Flow ofinformation
Communication
Flow ofinformation
Copyright CWRU-CME 2003All Rights Reserved
HFH
EA
RT
FA
ILU
RE
Evaluate AssessmentHospital team reviews summary
reports and current protocols
Refine ProtocolsHospital team identifiesareas for improvement
Implement Refined ProtocolsHospital team coordinates
implementation of refined protocols
Find and Support a ChampionFind and Support a Champion
Assess HF Treatment RatesMeasure current treatment rates
and process-of-care indicators
GWTG-HF Cycle of Quality Improvement
A Call to Action• Care about core measures, performance
measures, and outcomes!• Get involved with the development of the
measures – know what it means for you• Understand what is required of you to meet
performance measures• Document your adherence to guidelines/PM• Find opportunities for improvement• Demonstrate to your patients that you have
quality outcomes
What is H2H?
• National Rallying Point• Catalyze Action• Leverage Other Initiatives• Rapid Learning Community• Building on Success
Hospital to Home (H2H)Hospital to Home (H2H)A national quality improvement initiative of the American College of Cardiology and the Institute for Healthcare Improvement
Building on SuccessBuilding on Success•ACC’s Door to Balloon: An Alliance for Quality•IHI’s 100K Lives & 5M Lives Campaigns
GoalGoalReduce 30 day, all-cause, risk standardized readmission rates (RSRR) for patients discharged with cardiac conditions by 20% by December 2012.
H2H Core ConceptsH2H Core Concepts• Post-discharge medication management. Patients must
not only have access to the proper medications, they need to be properly educated on how to use them.
• Early follow-up. Discharged patients should have a follow- up visit scheduled within a week of discharge, as well as the means of getting to that appointment.
• Symptom management. Patients must recognize the signs and symptoms that require medical attention, as well as the appropriate person to contact if those signs/symptoms appear.
Copyright CWRU-CME 2003All Rights Reserved
“Hospitals and clinicians have no way to assess and benchmark overall clinical performance from the patient’s perspective.”Krumholz
and Normand, Circ 2008
After all…..Isn’t it all about the PATIENT?